Vas Narasimhan is not your typical CEO, having started his career in public health, where he became passionate about how to impact health on a large scale. Now, many years later and a little over a year into his role as CEO of Novartis, his passion remains undiminished. The impact the company is having on patients is remarkable, be it with “miraculous” treatments that cure children of deadly diseases with one pill, or with the Novartis Access program.
In the second half of my interview with him, we talk about some of the changes underway in Novartis, such as how AI is being used to overcome organizational biases, the importance of both big “P” and small “p” purpose in an organization of 125,000 associates, of whom over 50% are millennials, and the 5 year cultural transformation the company has embarked on.
Read the full article HERE.
Links and Resources Mentioned in This Episode:
- Novartis
- Novartis Access
- Follow Vas Narasimhan on LinkedIn and Twitter
- Unboss by Jacob Bøtter and Lars Kolind
- The Prosperity Paradox: How Innovation Can Lift Nations Out of Poverty by Clayton Christensen, Efosa Ojomo and Karen Dillon
